Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Alteration of PBMC transcriptome profile after interaction with multipotent mesenchymal stromal cells under "physiological" hypoxia.

Gornostaeva AN., Bobyleva PI., Andreeva ER., Gogiya BS., Buravkova LB.

Laboratory Study on Chronic Inflammation, published in Immunobiology (2023) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Immunobiology (2023)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
38091798
DOI
10.1016/j.imbio.2023.152766

Abstract (original English)

Multipotent mesenchymal stromal cells (MSCs) have demonstrated a pronounced immunosuppressive activity, the manifestation of which depends on the microenvironmental factors, including O 2 level. Here we examined the effects of MSCs on transcriptomic profile of allogeneic phytohemagglutinin-stimulated peripheral blood mononuclear cells (PBMCs) after interaction at ambient (20%) or "physiological" hypoxia (5%) O 2 . As revealed with microarray analysis, PBMC transcriptome at 20% O 2 was more affected, which was manifested as differential expression of more than 300 genes, whereas under 5% O 2 220 genes were changed. Most of genes at 20% O 2 were downregulated, while at hypoxia most of genes were upregulated. Altered gene patterns were only partly overlapped at different O 2 levels. A set of altered genes at hypoxia only was of particular interest. According to Gene Ontology a part of above genes was responsible for adhesion, cell communication, and immune response. At both oxygen concentrations, MSCs demonstrated effective immunosuppression manifested as attenuation of T cell activation and proliferation as well as anti-inflammatory shift of cytokine profile. Thus, MSC-mediated immunosuppression is executed with greater efficacy at a "physiological" hypoxia, since the same result has been achieved through a change in the expression of a fewer genes in target PBMCs.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansTranscriptomeLeukocytes, MononuclearMesenchymal Stem CellsCell CommunicationHypoxiaCells, CulturedCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research